Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent
11/19/2008EP1992347A1 Treatment of DDR1 positive cancer using imatinib
11/19/2008EP1992344A1 P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1991869A2 Methods for the diagnosis of proliferative and/or conformational diseases
11/19/2008EP1991561A2 Branched multimeric peptides for tumor diagnosis and therapy
11/19/2008EP1991556A1 Ruthenium (ii) compounds
11/19/2008EP1991554A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them
11/19/2008EP1991543A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors
11/19/2008EP1991538A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
11/19/2008EP1991535A1 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
11/19/2008EP1991526A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
11/19/2008EP1991274A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
11/19/2008EP1991246A2 Treatment of development-related disorders
11/19/2008EP1991239A1 Doxorubicin formulations for anti-cancer use
11/19/2008EP1991231A1 Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
11/19/2008EP1991230A1 Methods of treating cancer
11/19/2008EP1991056A2 Mannose derivatives for killing tumor cells
11/19/2008EP1853606B1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/19/2008EP1753727B1 Novel cis-imidazolines
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1537108B1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
11/19/2008EP1532138B1 Inhibitors of tyrosine kinases
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1427326B1 Combination therapy for the treatment of cancer
11/19/2008EP1377667B1 Fusion proteins for specific treatment of cancer and auto-immune diseases
11/19/2008EP1372650B1 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
11/19/2008EP1349545B1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008EP1206555B1 Fv antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein
11/19/2008EP1112084B1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
11/19/2008EP0802921B1 Human pak65
11/19/2008CN101309923A N-sulfamoyl-N -benzopyranpiperidines as inhibitors of carbonic anhydrases
11/19/2008CN101309908A Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/19/2008CN101309706A Controlled drug release composition and drug releasing medical device
11/19/2008CN101309700A Therapeutic use of outer shigella protein f (ospf)
11/19/2008CN101309697A Method of treating patients with a mucinous glycoprotein (muc-1) vaccine
11/19/2008CN101309686A Unit dosage forms of temozolomide
11/19/2008CN101309681A Combinations comprising dmxaa for the treatment of cancer
11/19/2008CN101307330A BA46 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307329A Her-2/neu recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307328A CK19 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307327A CEA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307326A PSA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307325A PSMA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307304A Anti-human ovarian carcinoma anti-anti-idiotype antibody hybridoma cell line, and monoclonal antibody and application thereof
11/19/2008CN101307110A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307106A Endothelial cell proliferation inhibitor and method of use
11/19/2008CN101307094A Novel nuclear factor ¿Ckappa B p65 subunit antagonizing polypeptide
11/19/2008CN101307089A 2-imidazolyl-4-alkenyl-3-sterone and glyoxaline salt thereof and preparation method
11/19/2008CN101307084A Synthetic process of decitabine
11/19/2008CN101307082A Galactose-artemisinin and method for preparing same
11/19/2008CN101307078A Galactosyl thiourea heterocyclic compounds, synthetic method thereof and antineoplastic applications
11/19/2008CN101307059A Eriocalyxin B derivates, preparation method thereof and applications in antineoplastic drugs
11/19/2008CN101307052A Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof
11/19/2008CN101307050A Oxazole substituted dihydro pyrazol multi-heterocyclic ring derivates, preparation method and uses thereof
11/19/2008CN101307047A Heterocyclic compounds and applications thereof as antineoplastic drugs
11/19/2008CN101307041A Novel taxane halogenation derivates with anti-tumor activity
11/19/2008CN101307038A 4- benzyl piperazi ethyliminumacyl (formimidoyl benzol)hydrazine compounds, preparation method thereof, pharmaceutical compositions and use
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306996A Taxane compounds with oxygen-containing substituent at C-6, C-7 and C-9 positions
11/19/2008CN101306195A Recombination human soluble tumor necrosis factor related apoptosis inducing ligand freeze dried protection agents and preparation method thereof
11/19/2008CN101306192A Use of neuritis auxin in preparing antineoplastic medicine
11/19/2008CN101306184A Common turmeric extract vein emulsion injection and its preparation method and use
11/19/2008CN101306183A Common turmeric extract fat emulsion injection and its preparation method and use
11/19/2008CN101306182A Elemene vein emulsion injection and preparation method thereof
11/19/2008CN101306181A Elemene fat emulsion injection and preparation method thereof
11/19/2008CN101306176A Traditional Chinese medicine paste, its preparation method and use
11/19/2008CN101306130A Sanjialongdan Ruangan pill
11/19/2008CN101306118A Xuekangfu pill
11/19/2008CN101306094A Use of extraction of Radix et Rhizome Thalictri in preparing antineoplastic medicaments
11/19/2008CN101306093A Decoction for treating esophagus cancer haematemesis
11/19/2008CN101306083A Use of stephanotis extract in preparing antineoplastic agents
11/19/2008CN101306077A Chinese traditional injection preparation for treating cancer and its preparation method
11/19/2008CN101306076A Use of Erythrina bark extract in preparing antineoplastic medicine
11/19/2008CN101306072A Gadol buccal tablet and its preparation method
11/19/2008CN101306066A Use of narrow leaf symphytum asperum in preparing anti-cancer medicine
11/19/2008CN101306028A Use of asafetida volatile oil in preparing anticancer medicine
11/19/2008CN101306027A Extracting method of medical mangrove acanthus total flavonoids
11/19/2008CN101306025A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of brucea fruit volatile oil, its preparation method and use
11/19/2008CN101306023A New use of spikemoss extract
11/19/2008CN101306020A Use of clostridium butyricum in preparing medicine composition for preventing and curing intestinal cancer
11/19/2008CN101306013A Use of modified polysaccharide rich in galactose in preparing medicine for preventing the colitis cancer
11/19/2008CN101306012A Use of modified polysaccharide rich in mannose in preparing medicine for preventing the colitis cancer
11/19/2008CN101305999A Use of 2-alkyl substituted 4,6-diamino-1,3-5-triazine derivate
11/19/2008CN101305998A Use of aryl-3-substituted carbonyl pyridone compound
11/19/2008CN101305992A Compound sustained-released injection containing neonatal blood vessel restraining agent
11/19/2008CN101305991A Compound sustained-released injection containing neonatal blood vessel restraining agent
11/19/2008CN101305990A Use of EDG receptor binding agents in cancer
1 ... 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 ... 2211